Press Room

CPHI Japan 2025

Start
Wednesday, April 09, 2025 - 09:00
End
Friday, April 11, 2025 - 18:00
Location: Tokyo, Japan
Booth Number: 5N-21
Hovione is present at CPHI Japan in Tokyo | Hovione

Hovione is exhibiting at CPHI Japan, a renowned meeting place for suppliers and buyers from the entire pharmaceutical supply chain, bringing leading pharma professionals together to network, learn and conduct vital face-to-face business.

Meet the Hovione team at booth #5N-21 and learn more about our latest technologies and innovations in drug product development and how we can support your project providing optimal solutions with the right scale and flexibility. 

We look forward to seeing you at CPHI Japan. 
Schedule a meeting today.

 

schedule a meeting

 

Also in the Press Room

See All

The global inhalation contract development and manufacturing organization (CDMO) market is projected to grow from USD 9.13 billion in 2025 to USD 16.68 billion by 2035, reflecting a compound annual growth rate (CAGR) of 5.7% during the forecast period. This growth is driven by the increasing prevalence of respiratory diseases, advancements in inhalation drug delivery technologies, and the rising demand for outsourced manufacturing services in the pharmaceutical industry. The inhalation CDMO market has emerged as a pivotal segment in the pharmaceutical contract development and manufacturing industry. With a rising demand for inhaled therapies for conditions like asthma, COPD, and cystic fibrosis, companies are increasingly outsourcing drug development and production to specialized partners. Inhalation CDMO services cater to both large pharmaceutical corporations and small biotech firms, offering expertise in formulation, device compatibility, regulatory support, and scale-up manufacturing. This market is gaining traction due to the complexity of inhalation drug delivery, which often requires niche technical capabilities and specialized equipment. Outsourcing to an inhalation CDMO allows drug developers to reduce time-to-market while ensuring quality and compliance with global standards. (...) Top Companies Several players dominate the inhalation CDMO market through technological expertise, global reach, and service portfolio diversity: (...) Hovione – Offers particle engineering and inhalation development, with a focus on dry powder inhalers. (...) These companies are continually investing in facilities, talent, and technology to meet evolving customer needs in the inhalation CDMO market.   Read the full article on Pharmiweb.com        

Press Clipping

Inhalation CDMO Market Growth Analysis & Forecast 2025 to 2035

Jun 25, 2025